CME vs FDS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

CME

37.7
AI Score
VS
FDS Wins

FDS

47.8
AI Score

Investment Advisor Scores

CME

38score
Recommendation
SELL

FDS

48score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CME FDS Winner
Revenue 3.59B 1.84B CME
Net Income 2.20B 412.35M CME
Net Margin 61.2% 22.4% CME
Operating Income 2.42B 543.33M CME
ROE 8.3% 20.3% FDS
ROA 1.1% 9.8% FDS
Total Assets 194.68B 4.19B CME
Cash 2.14B 288.11M CME
Current Ratio 1.02 0.68 CME

Relative Price Performance (Last 90 Days)

CME 1M: +8.1% · 3M: -4.9% FDS 1M: +22.9% · 3M: +33.3%

Current Technical Phase

CME

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 65

RSI (14): 64.7 · Price: $274.98

FDS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.5% over 20 days), RSI 66

RSI (14): 65.9 · Price: $299.91

Fundamentals Snapshot

Metric CME FDS
Market Cap
Forward P/E 21.3 15.2
Trailing P/E 22.6 19.7
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin 0.7% 0.3%
EPS 11.97 15.27
Dividend Yield 0.02% 0.02%

Frequently Asked Questions

Based on our detailed analysis, FDS is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.